These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 32427080)

  • 21. Preparation and characterization of nanoparticles containing an atypical antipsychotic agent.
    Singh S; Muthu MS
    Nanomedicine (Lond); 2007 Apr; 2(2):233-40. PubMed ID: 17716123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly(ε-caprolactone)/triclosan loaded polylactic acid nanoparticles composite: A long-term antibacterial bionanocomposite with sustained release.
    Kaffashi B; Davoodi S; Oliaei E
    Int J Pharm; 2016 Jul; 508(1-2):10-21. PubMed ID: 27155590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of different types of nano drug delivery systems of atorvastatin for the treatment of hyperlipidemia.
    Mathur M; Devi Vemula K
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2048-2060. PubMed ID: 30073852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depot injectable biodegradable nanoparticles loaded with recombinant human bone morphogenetic protein-2: preparation, characterization, and in vivo evaluation.
    Hassan AH; Hosny KM; Murshid ZA; Alhadlaq A; Alyamani A; Naguib G
    Drug Des Devel Ther; 2015; 9():3599-606. PubMed ID: 26203226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid poly (ɛ-caprolactone) hybrid nanoparticles of 5-fluorouracil for sustained release and enhanced anticancer efficacy.
    Khan S; Aamir MN; Madni A; Jan N; Khan A; Jabar A; Shah H; Rahim MA; Ali A
    Life Sci; 2021 Nov; 284():119909. PubMed ID: 34450169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Porous poly(ε-caprolactone) implants: A novel strategy for efficient intraocular drug delivery.
    Boia R; Dias PAN; Martins JM; Galindo-Romero C; Aires ID; Vidal-Sanz M; Agudo-Barriuso M; de Sousa HC; Ambrósio AF; Braga MEM; Santiago AR
    J Control Release; 2019 Dec; 316():331-348. PubMed ID: 31715277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local delivery of modified paclitaxel-loaded poly(epsilon-caprolactone)/pluronic F68 nanoparticles for long-term inhibition of hyperplasia.
    Mei L; Sun H; Song C
    J Pharm Sci; 2009 Jun; 98(6):2040-50. PubMed ID: 18855915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrocortisone loaded poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for topical ophthalmic administration: Preparation, characterization and evaluation of ophthalmic toxicity.
    Álvarez-Álvarez L; Barral L; Bouza R; Farrag Y; Otero-Espinar F; Feijóo-Bandín S; Lago F
    Int J Pharm; 2019 Sep; 568():118519. PubMed ID: 31310791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation, in vitro characterization and in vivo release of naproxen loaded in poly-caprolactone nanoparticles.
    Rodrigues MR; Lanzarini CM; Ricci-Junior E
    Pharm Dev Technol; 2011 Feb; 16(1):12-21. PubMed ID: 20001271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and development of dual drug-loaded nanofibrous inserts for ophthalmic sustained delivery of AMK and VAN: Pharmacokinetic study in rabbit's eye.
    Taghe S; Mirzaeei S; Hosseinkhani T
    Int J Pharm; 2024 May; 656():124056. PubMed ID: 38548072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratumoral administration of carboplatin bearing poly (ε-caprolactone) nanoparticles amalgamated with in situ gel tendered augmented drug delivery, cytotoxicity, and apoptosis in melanoma tumor.
    Bragta P; Sidhu RK; Jyoti K; Baldi A; Jain UK; Chandra R; Madan J
    Colloids Surf B Biointerfaces; 2018 Jun; 166():339-348. PubMed ID: 29627747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly(ε-caprolactone) nanocapsule carriers with sustained drug release: single dose for long-term glaucoma treatment.
    Lee CH; Li YJ; Huang CC; Lai JY
    Nanoscale; 2017 Aug; 9(32):11754-11764. PubMed ID: 28782783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly(3-hydroxybutyrate-co-epsilon-caprolactone) copolymers and poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-epsilon-caprolactone) terpolymers as novel materials for colloidal drug delivery systems.
    Pignatello R; Musumeci T; Impallomeni G; Carnemolla GM; Puglisi G; Ballistreri A
    Eur J Pharm Sci; 2009 Jun; 37(3-4):451-62. PubMed ID: 19504659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A sustained release formulation of chitosan modified PLCL:poloxamer blend nanoparticles loaded with optical agent for animal imaging.
    Ranjan AP; Zeglam K; Mukerjee A; Thamake S; Vishwanatha JK
    Nanotechnology; 2011 Jul; 22(29):295104. PubMed ID: 21693801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel self-assembled core-shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release.
    Papadimitriou S; Bikiaris D
    J Control Release; 2009 Sep; 138(2):177-84. PubMed ID: 19446585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-assembled honokiol-loaded micelles based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.
    Wei X; Gong C; Shi S; Fu S; Men K; Zeng S; Zheng X; Gou M; Chen L; Qiu L; Qian Z
    Int J Pharm; 2009 Mar; 369(1-2):170-5. PubMed ID: 19028556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles.
    Mady FM; Shaker MA
    Int J Nanomedicine; 2017; 12():7405-7417. PubMed ID: 29066891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo tissue distribution and efficacy studies for cyclosporin A loaded nano-decorated subconjunctival implants.
    Yavuz B; Bozdağ Pehlivan S; Kaffashi A; Çalamak S; Ulubayram K; Palaska E; Çakmak HB; Ünlü N
    Drug Deliv; 2016 Nov; 23(9):3279-3284. PubMed ID: 27027148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DoE based Olanzapine loaded poly-caprolactone nanoparticles decreases extrapyramidal effects in rodent model.
    Joseph E; Reddi S; Rinwa V; Balwani G; Saha R
    Int J Pharm; 2018 Apr; 541(1-2):198-205. PubMed ID: 29474898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments.
    Shahab MS; Rizwanullah M; Alshehri S; Imam SS
    Int J Biol Macromol; 2020 Nov; 163():2392-2404. PubMed ID: 32979440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.